Rui Chen1, Silvia Giliani2, Gaetana Lanzi2, George I Mias1, Silvia Lonardi3, Kerry Dobbs4, John Manis5, Hogune Im1, Jennifer E Gallagher1, Douglas H Phanstiel1, Ghia Euskirchen1, Philippe Lacroute1, Keith Bettinger1, Daniele Moratto2, Katja Weinacht6, Davide Montin7, Eleonora Gallo7, Giovanna Mangili8, Fulvio Porta9, Lucia D Notarangelo9, Stefania Pedretti8, Waleed Al-Herz10, Wasmi Alfahdli11, Anne Marie Comeau12, Russell S Traister13, Sung-Yun Pai14, Graziella Carella15, Fabio Facchetti3, Kari C Nadeau16, Michael Snyder17, Luigi D Notarangelo18. 1. Department of Genetics, Stanford University School of Medicine, Stanford, Calif. 2. A. Nocivelli Institute for Molecular Medicine, Pediatric Clinic, University of Brescia, and the Section of Genetics, Department of Pathology Spedali Civili, Brescia, Italy. 3. Department of Pathology, University of Brescia, Brescia, Italy. 4. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Harvard Stem Cell Institute, Boston, Mass. 5. Department of Transfusion Medicine, Boston Children's Hospital, Boston, Mass. 6. Division of Hematology and Oncology, Boston Children's Hospital, Boston, Mass. 7. Department of Public Health and Pediatrics, University of Torino, Torino, Italy. 8. USC Patologia Neonatale, Ospedali Riuniti di Bergamo, Bergamo, Italy. 9. Division of Pediatric Hematology-Oncology, Spedali Civili Brescia, Brescia, Italy. 10. Department of Pediatrics, Al-Sabah Hospital, Kuwait City, Kuwait. 11. Department of Surgery, Ibn-Sina Hospital, Kuwait City, Kuwait. 12. New England Newborn Screening Program, University of Massachusetts Medical School, Worcester, Mass. 13. Department of Internal Medicine, Children's Hospital of Pittsburgh, Pittsburgh, Pa. 14. Division of Hematology-Oncology, Boston Children's Hospital, Boston, Mass. 15. Clinical Immunology and Allergology, Spedali Civili Brescia, Brescia, Italy. 16. Department of Pediatrics, Stanford University School of Medicine, Stanford, Calif. Electronic address: knadeau@stanford.edu. 17. Department of Genetics, Stanford University School of Medicine, Stanford, Calif. Electronic address: mpsnyder@stanford.edu. 18. Division of Immunology, Boston Children's Hospital, Harvard Medical School, Harvard Stem Cell Institute, Boston, Mass; Harvard Stem Cell Institute, Harvard Medical School, Boston, Mass. Electronic address: Luigi.Notarangelo@childrens.harvard.edu.
Abstract
BACKGROUND: Combined immunodeficiency with multiple intestinal atresias (CID-MIA) is a rare hereditary disease characterized by intestinal obstructions and profound immune defects. OBJECTIVE: We sought to determine the underlying genetic causes of CID-MIA by analyzing the exomic sequences of 5 patients and their healthy direct relatives from 5 unrelated families. METHODS: We performed whole-exome sequencing on 5 patients with CID-MIA and 10 healthy direct family members belonging to 5 unrelated families with CID-MIA. We also performed targeted Sanger sequencing for the candidate gene tetratricopeptide repeat domain 7A (TTC7A) on 3 additional patients with CID-MIA. RESULTS: Through analysis and comparison of the exomic sequence of the subjects from these 5 families, we identified biallelic damaging mutations in the TTC7A gene, for a total of 7 distinct mutations. Targeted TTC7A gene sequencing in 3 additional unrelated patients with CID-MIA revealed biallelic deleterious mutations in 2 of them, as well as an aberrant splice product in the third patient. Staining of normal thymus showed that the TTC7A protein is expressed in thymic epithelial cells, as well as in thymocytes. Moreover, severe lymphoid depletion was observed in the thymus and peripheral lymphoid tissues from 2 patients with CID-MIA. CONCLUSIONS: We identified deleterious mutations of the TTC7A gene in 8 unrelated patients with CID-MIA and demonstrated that the TTC7A protein is expressed in the thymus. Our results strongly suggest that TTC7A gene defects cause CID-MIA.
BACKGROUND: Combined immunodeficiency with multiple intestinal atresias (CID-MIA) is a rare hereditary disease characterized by intestinal obstructions and profound immune defects. OBJECTIVE: We sought to determine the underlying genetic causes of CID-MIA by analyzing the exomic sequences of 5 patients and their healthy direct relatives from 5 unrelated families. METHODS: We performed whole-exome sequencing on 5 patients with CID-MIA and 10 healthy direct family members belonging to 5 unrelated families with CID-MIA. We also performed targeted Sanger sequencing for the candidate gene tetratricopeptide repeat domain 7A (TTC7A) on 3 additional patients with CID-MIA. RESULTS: Through analysis and comparison of the exomic sequence of the subjects from these 5 families, we identified biallelic damaging mutations in the TTC7A gene, for a total of 7 distinct mutations. Targeted TTC7A gene sequencing in 3 additional unrelated patients with CID-MIA revealed biallelic deleterious mutations in 2 of them, as well as an aberrant splice product in the third patient. Staining of normal thymus showed that the TTC7A protein is expressed in thymic epithelial cells, as well as in thymocytes. Moreover, severe lymphoid depletion was observed in the thymus and peripheral lymphoid tissues from 2 patients with CID-MIA. CONCLUSIONS: We identified deleterious mutations of the TTC7A gene in 8 unrelated patients with CID-MIA and demonstrated that the TTC7A protein is expressed in the thymus. Our results strongly suggest that TTC7A gene defects cause CID-MIA.
Authors: Aaron McKenna; Matthew Hanna; Eric Banks; Andrey Sivachenko; Kristian Cibulskis; Andrew Kernytsky; Kiran Garimella; David Altshuler; Stacey Gabriel; Mark Daly; Mark A DePristo Journal: Genome Res Date: 2010-07-19 Impact factor: 9.043
Authors: Richard K Gilroy; Peter F Coccia; James E Talmadge; Lori I Hatcher; Samuel J Pirruccello; Byers W Shaw; Ronald J Rubocki; Debra L Sudan; Alan N Langnas; Simon P Horslen Journal: Blood Date: 2003-10-02 Impact factor: 22.113
Authors: Sonja Kimmig; Grzegorz K Przybylski; Christian A Schmidt; Katja Laurisch; Beate Möwes; Andreas Radbruch; Andreas Thiel Journal: J Exp Med Date: 2002-03-18 Impact factor: 14.307
Authors: Mark E Samuels; Jacek Majewski; Najmeh Alirezaie; Isabel Fernandez; Ferran Casals; Natalie Patey; Hélène Decaluwe; Isabelle Gosselin; Elie Haddad; Alan Hodgkinson; Youssef Idaghdour; Valerie Marchand; Jacques L Michaud; Marc-André Rodrigue; Sylvie Desjardins; Stéphane Dubois; Francoise Le Deist; Philip Awadalla; Vincent Raymond; Bruno Maranda Journal: J Med Genet Date: 2013-02-19 Impact factor: 6.318
Authors: Jessica R Saunders; Anna Lehman; Stuart E Turvey; Jie Pan; Evica Rajcan-Separovic; Aleixo M Muise; Jonathan W Bush Journal: J Clin Immunol Date: 2019-07-24 Impact factor: 8.317
Authors: Yaron Avitzur; Conghui Guo; Lucas A Mastropaolo; Ehsan Bahrami; Hannah Chen; Zhen Zhao; Abdul Elkadri; Sandeep Dhillon; Ryan Murchie; Ramzi Fattouh; Hien Huynh; Jennifer L Walker; Paul W Wales; Ernest Cutz; Yoichi Kakuta; Joel Dudley; Jochen Kammermeier; Fiona Powrie; Neil Shah; Christoph Walz; Michaela Nathrath; Daniel Kotlarz; Jacek Puchaka; Jonathan R Krieger; Tomas Racek; Thomas Kirchner; Thomas D Walters; John H Brumell; Anne M Griffiths; Nima Rezaei; Parisa Rashtian; Mehri Najafi; Maryam Monajemzadeh; Stephen Pelsue; Dermot P B McGovern; Holm H Uhlig; Eric Schadt; Christoph Klein; Scott B Snapper; Aleixo M Muise Journal: Gastroenterology Date: 2014-01-11 Impact factor: 22.682